Related references
Note: Only part of the references are listed.Cytokines as molecular targets for aryl hydrocarbon receptor ligands: implications for toxicity and xenobiotic detoxification
Olivier Fardel
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cells
Barbara C. Spink et al.
MOLECULAR CARCINOGENESIS (2013)
Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation
Guofeng Xie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Activation of the aryl hydrocarbon receptor represses mammosphere formation in MCF-7 cells
Shuai Zhao et al.
CANCER LETTERS (2012)
The aryl hydrocarbon receptor as a promoter of malignant glioma
Michael Platten et al.
CELL CYCLE (2012)
The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis
Ivan Monteleone et al.
CURRENT OPINION IN GASTROENTEROLOGY (2012)
The effect of aryl hydrocarbon receptor ligands on the expression of polymerase (DNA directed) kappa (Polκ), polymerase RNA II (DNA directed) polypeptide A (Po1R2a), CYP1B1 and CYP1A1 genes in rat liver
Damian Brauze et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2012)
Effects of flavored mineral waters on AhR-CYP1A1 signaling pathway in primary human hepatocytes and in human hepatic and intestinal cancer cells
Alzbeta Kamenickova et al.
FOOD AND CHEMICAL TOXICOLOGY (2012)
Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss
Shelli M. Morris et al.
HEPATOLOGY (2012)
A selective aryl hydrocarbon receptor modulator 3,3′-Diindolylmethane inhibits gastric cancer cell growth
Xiao-Fei Yin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma
Jing-Houng Wang et al.
JOURNAL OF HEPATOLOGY (2012)
Aryl Hydrocarbon Receptor Agonists Induce MicroRNA-335 Expression and Inhibit Lung Metastasis of Estrogen Receptor Negative Breast Cancer Cells
Shu Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2012)
2-Amino-3-Methylimidazo[4,5-f]Quinoline (IQ) Promotes Mouse Hepatocarcinogenesis by Activating Transforming Growth Factor-β and Wnt/β-Catenin Signaling Pathways
Xiao-Li Xie et al.
TOXICOLOGICAL SCIENCES (2012)
Selective Aryl Hydrocarbon Receptor Modulator-Mediated Repression of CD55 Expression Induced by Cytokine Exposure
Gitanjali A. Narayanan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Molecular Pathogenesis of Hepatocellular Carcinoma: Altering Transforming Growth Factor-beta Signaling in Hepatocarcinogenesis
Ken Yamazaki et al.
DIGESTIVE DISEASES (2011)
The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease
Jinhan He et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Phenotype of single hepatocytes expressing an activated version of β-catenin in liver of transgenic mice
Sandra Schreiber et al.
JOURNAL OF MOLECULAR HISTOLOGY (2011)
Cooperation of deregulated Notch signaling and Ras pathway in human hepatocarcinogenesis
Renhua Fan et al.
JOURNAL OF MOLECULAR HISTOLOGY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Roles for Rat Hepatocyte Malignant Transforming Factor (HMTF) in Late Stage of Hepatocarcinogenesis
Shugo Suzuki et al.
TOXICOLOGIC PATHOLOGY (2011)
Upregulation of the Insulin Receptor and Type I Insulin-Like Growth Factor Receptor Are Early Events in Hepatocarcinogenesis
Eiman Aleem et al.
TOXICOLOGIC PATHOLOGY (2011)
Mitochondrial Prohibitins and Septin 9 Are Implicated in the Onset of Rat Hepatocarcinogenesis
Anna Kakehashi et al.
TOXICOLOGICAL SCIENCES (2011)
Late SV40 factor: A key mediator of Notch signaling in human hepatocarcinogenesis
Ren-Hua Fan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
The Aryl Hydrocarbon Receptor Functions as a Tumor Suppressor of Liver Carcinogenesis
Yunxia Fan et al.
CANCER RESEARCH (2010)
High expression levels of IKKα and IKKβ are necessary for the malignant properties of liver cancer
Runqiu Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2010)
Expression of Aryl Hydrocarbon Receptor in Human Placentas and Fetal Tissues
Yi-zhou Jiang et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2010)
Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity
Gernot Zollner et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Functional analysis of six human aryl hydrocarbon receptor variants in human breast cancer and mouse hepatoma cell lines
Trine Celius et al.
TOXICOLOGY (2010)
2,3,7,8-Tetrachlorodibenzo-p-dioxin increases reactive oxygen species production in human endothelial cells via induction of cytochrome P4501A1
P. G. Kopf et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
The selective aryl hydrocarbon receptor modulator 6-methyl-1,3,8-trichlorodibenzofuran inhibits prostate tumor metastasis in TRAMP mice
Wayne A. Ftitz et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity
L-C Bui et al.
ONCOGENE (2009)
Aryl hydrocarbon receptor inhibition downregulates the TGF-β/Smad pathway in human glioblastoma cells
D. Gramatzki et al.
ONCOGENE (2009)
Therapeutic potential of dithiolethiones for hepatic diseases
Samuel Carroll Brooks et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in Apc>Min/+ mice with natural ligands
Kaname Kawajiri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer
Tie-Li Peng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Cross-talk between aryl hydrocarbon receptor and mitogen-activated protein kinase signaling pathway in liver cancer through c-raf transcriptional regulation
Juergen Borlak et al.
MOLECULAR CANCER RESEARCH (2008)
A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis
Jennifer J. Schlezinger et al.
BIOLOGICAL CHEMISTRY (2006)
Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells
M Abdelrahim et al.
MOLECULAR PHARMACOLOGY (2003)
Ligand binding and activation of the Ah receptor
MS Denison et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2002)
Share Paper
